Physician profile
Elizabeth Wright
NPI 1578198222
$6,128.73
in general payments reported to CMS, 2019-2025
29 companies · $3,325 in 2025
The $3,325 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $565 · 2023: $692 · 2024: $1,323 · 2025: $3,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,684 · Travel and Lodging: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,684.41 |
| Travel and Lodging | $656.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $1,788.07 | 2024-2025 | Optimizer |
| Novo Nordisk INC | $1,232.26 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abiomed | $530.01 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $441.07 | 2024-2025 | Lifevest |
| Lilly USA, LLC | $393.77 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boston Scientific Corporation | $215.02 | 2022-2023 | Resonate El Icd Vr |
| Merck Sharp & Dohme LLC | $167.39 | 2024-2025 | Verquvo, Capvaxive |
| Sanofi-Aventis U.S. LLC | $161.13 | 2022-2024 | |
| Endologix LLC | $147.75 | 2025 | Endocross Device, Torus Stent Graft System |
| Abbvie INC. | $122.14 | 2021-2023 | |
| Kestra Medical Technology Services, INC. | $101.55 | 2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $101.48 | 2021-2025 | Farxiga, Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $89.39 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $83.07 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.09 | 2023-2025 | Jardiance, Tradjenta, Synjardy |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $75.49 | 2022-2024 | Repatha |
| Inspire Medical Systems, INC. | $71.75 | 2024 | Inspire |
| Radius Health, INC. | $64.43 | 2023-2024 | Tymlos |
| Glaxosmithkline, LLC. | $64.22 | 2022-2025 | Nucala |
| Alexion Pharmaceuticals, INC. | $46.19 | 2023-2024 | Strensiq |
| Mimedx Group, INC. | $24.92 | 2024 | |
| Horizon Therapeutics Plc | $22.17 | 2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $18.96 | 2021 | |
| Tolmar, INC. | $17.08 | 2024 | |
| Amarin Pharma, INC. | $16.23 | 2022 | |
| Pfizer INC. | $16.00 | 2025 | |
| Tactile Systems Technology INC | $15.83 | 2024 | Flexitouch Plus, Entre Plus |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2025 | Camzyos |
| Cashflow Solutions, LLC | $6.27 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.